These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34905965)

  • 41. Australian critical care nurses' knowledge, preparedness, and experiences of managing SARS-COV-2 and COVID-19 pandemic.
    Nahidi S; Sotomayor-Castillo C; Li C; Currey J; Elliott R; Shaban RZ
    Aust Crit Care; 2022 Jan; 35(1):22-27. PubMed ID: 34462194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiome Analysis for Wastewater Surveillance during COVID-19.
    Brumfield KD; Leddy M; Usmani M; Cotruvo JA; Tien CT; Dorsey S; Graubics K; Fanelli B; Zhou I; Registe N; Dadlani M; Wimalarante M; Jinasena D; Abayagunawardena R; Withanachchi C; Huq A; Jutla A; Colwell RR
    mBio; 2022 Aug; 13(4):e0059122. PubMed ID: 35726918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence.
    Golding N; Price DJ; Ryan G; McVernon J; McCaw JM; Shearer FM
    Elife; 2023 Jan; 12():. PubMed ID: 36661303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia.
    Milne GJ; Xie S; Poklepovich D; O'Halloran D; Yap M; Whyatt D
    Sci Rep; 2021 Jun; 11(1):11958. PubMed ID: 34099788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhancing COVID-19 Epidemic Forecasting Accuracy by Combining Real-time and Historical Data From Multiple Internet-Based Sources: Analysis of Social Media Data, Online News Articles, and Search Queries.
    Li J; Huang W; Sia CL; Chen Z; Wu T; Wang Q
    JMIR Public Health Surveill; 2022 Jun; 8(6):e35266. PubMed ID: 35507921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Wastewater surveillance-based city zonation for effective COVID-19 pandemic preparedness powered by early warning: A perspectives of temporal variations in SARS-CoV-2-RNA in Ahmedabad, India.
    Kumar M; Joshi M; Shah AV; Srivastava V; Dave S
    Sci Total Environ; 2021 Oct; 792():148367. PubMed ID: 34465041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model-Estimated Association Between Simulated US Elementary School-Related SARS-CoV-2 Transmission, Mitigation Interventions, and Vaccine Coverage Across Local Incidence Levels.
    Giardina J; Bilinski A; Fitzpatrick MC; Kendall EA; Linas BP; Salomon J; Ciaranello AL
    JAMA Netw Open; 2022 Feb; 5(2):e2147827. PubMed ID: 35157056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemic Landscape and Forecasting of SARS-CoV-2 in India.
    Rajendrakumar AL; Nair ATN; Nangia C; Chourasia PK; Chourasia MK; Syed MG; Nair AS; Nair AB; Koya MSF
    J Epidemiol Glob Health; 2021 Mar; 11(1):55-59. PubMed ID: 32959618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022.
    Du Z; Tian L; Jin DY
    Emerg Microbes Infect; 2022 Dec; 11(1):1394-1401. PubMed ID: 35536564
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection.
    Colaneri M; Novelli V; Cutti S; Muzzi A; Resani G; Monti MC; Rona C; Grugnetti AM; Rettani M; Rovida F; Zuccaro V; Triarico A; Marena C
    J Public Health (Oxf); 2021 Apr; 43(1):26-34. PubMed ID: 33140084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria.
    Milazzo A; Giles L; Parent N; McCarthy S; Laurence C
    Aust N Z J Public Health; 2022 Aug; 46(4):482-487. PubMed ID: 35557482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia's surveillance system performance.
    Lokuge K; D'Onise K; Banks E; Street T; Jantos S; Baptista M; Glass K
    BMC Med; 2022 Apr; 20(1):157. PubMed ID: 35421989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infectious disease modelling for SARS-CoV-2 in Africa to guide policy: A systematic review.
    Kimani TN; Nyamai M; Owino L; Makori A; Ombajo LA; Maritim M; Anzala O; Thumbi SM
    Epidemics; 2022 Sep; 40():100610. PubMed ID: 35868211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delaying the COVID-19 epidemic in Australia: evaluating the effectiveness of international travel bans.
    Adekunle A; Meehan M; Rojas-Alvarez D; Trauer J; McBryde E
    Aust N Z J Public Health; 2020 Aug; 44(4):257-259. PubMed ID: 32697418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Model training periods impact estimation of COVID-19 incidence from wastewater viral loads.
    Daza-Torres ML; Montesinos-López JC; Kim M; Olson R; Bess CW; Rueda L; Susa M; Tucker L; García YE; Schmidt AJ; Naughton CC; Pollock BH; Shapiro K; Nuño M; Bischel HN
    Sci Total Environ; 2023 Feb; 858(Pt 1):159680. PubMed ID: 36306854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.
    Jelley L; Douglas J; Ren X; Winter D; McNeill A; Huang S; French N; Welch D; Hadfield J; de Ligt J; Geoghegan JL
    Nat Commun; 2022 Jul; 13(1):4035. PubMed ID: 35821124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A statistical framework for tracking the time-varying superspreading potential of COVID-19 epidemic.
    Guo Z; Zhao S; Lee SS; Hung CT; Wong NS; Chow TY; Yam CHK; Wang MH; Wang J; Chong KC; Yeoh EK
    Epidemics; 2023 Mar; 42():100670. PubMed ID: 36709540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.